Teva Pharmaceutical Industries Ltd (TEVA) — Strategic Asset Allocation Index
Teva Pharmaceutical Industries Ltd (TEVA) has a Strategic Asset Allocation Index of 79.5% as of June 2023. Strategic assets (PP&E of ILA6.13 Billion plus long-term investments of ILA-) total ILA6.13 Billion, measured against net assets of ILA7.71 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check TEVA asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Teva Pharmaceutical Industries Ltd Strategic Asset Allocation Index (2000–2022)
This chart shows how Teva Pharmaceutical Industries Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 79.5%, representing strategic assets of ILA6.13 Billion against net assets of ILA7.71 Billion ILA. See financial agility of Teva Pharmaceutical Industries Ltd to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Teva Pharmaceutical Industries Ltd (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Teva Pharmaceutical Industries Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Teva Pharmaceutical Industries Ltd (TEVA) total market value.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 70.9% | ILA6.16 Billion | ILA6.16 Billion | ILA- | ILA8.69 Billion | ▲ +13.3 pp |
| 2021 | 57.6% | ILA6.48 Billion | ILA6.48 Billion | ILA- | ILA11.24 Billion | ▼ -4.4 pp |
| 2020 | 62.0% | ILA6.86 Billion | ILA6.86 Billion | ILA- | ILA11.06 Billion | ▲ +15.8 pp |
| 2019 | 46.1% | ILA6.95 Billion | ILA6.95 Billion | ILA- | ILA15.06 Billion | ▲ +2.3 pp |
| 2018 | 43.9% | ILA6.93 Billion | ILA6.87 Billion | ILA61.00 Million | ILA15.79 Billion | ▲ +5.9 pp |
| 2017 | 38.0% | ILA7.12 Billion | ILA7.04 Billion | ILA83.00 Million | ILA18.75 Billion | ▲ +15.9 pp |
| 2016 | 22.1% | ILA7.72 Billion | ILA7.44 Billion | ILA283.00 Million | ILA34.99 Billion | ▼ -2.9 pp |
| 2015 | 25.0% | ILA7.47 Billion | ILA6.02 Billion | ILA1.45 Billion | ILA29.93 Billion | ▼ -1.3 pp |
| 2014 | 26.3% | ILA6.14 Billion | ILA5.96 Billion | ILA176.00 Million | ILA23.36 Billion | ▼ -0.6 pp |
| 2013 | 26.9% | ILA6.10 Billion | ILA5.92 Billion | ILA179.00 Million | ILA22.64 Billion | ▲ +2.5 pp |
| 2012 | 24.4% | ILA5.59 Billion | ILA5.59 Billion | ILA- | ILA22.87 Billion | ▲ +0.4 pp |
| 2011 | 24.0% | ILA5.37 Billion | ILA5.37 Billion | ILA- | ILA22.34 Billion | ▲ +5.7 pp |
| 2010 | 18.3% | ILA4.03 Billion | ILA4.03 Billion | ILA- | ILA22.00 Billion | ▲ +0.4 pp |
| 2009 | 17.9% | ILA3.46 Billion | ILA3.46 Billion | ILA- | ILA19.26 Billion | ▼ -3.0 pp |
| 2008 | 20.9% | ILA3.42 Billion | ILA3.42 Billion | ILA- | ILA16.36 Billion | ▲ +3.8 pp |
| 2007 | 17.2% | ILA2.36 Billion | ILA2.36 Billion | ILA- | ILA13.76 Billion | ▼ -1.2 pp |
| 2006 | 18.4% | ILA2.06 Billion | ILA2.06 Billion | ILA- | ILA11.18 Billion | ▼ -4.1 pp |
| 2005 | 22.5% | ILA1.36 Billion | ILA1.36 Billion | ILA- | ILA6.05 Billion | ▼ -1.2 pp |
| 2004 | 23.7% | ILA1.28 Billion | ILA1.28 Billion | ILA- | ILA5.40 Billion | ▼ -1.4 pp |
| 2003 | 25.1% | ILA827.40 Million | ILA827.40 Million | ILA- | ILA3.30 Billion | ▼ -11.7 pp |
| 2002 | 36.8% | ILA675.40 Million | ILA675.40 Million | ILA- | ILA1.83 Billion | ▼ -3.3 pp |
| 2001 | 40.1% | ILA554.14 Million | ILA554.14 Million | ILA- | ILA1.38 Billion | ▼ -6.3 pp |
| 2000 | 46.3% | ILA534.14 Million | ILA534.14 Million | ILA- | ILA1.15 Billion | — |